PRESS RELEASE published on 11/12/2025 at 07:30, 1 year ago Evotec receives milestone payment from Bristol Myers Squibb following IND acceptance in strategic protein degradation partnership Evotec receives US$ 5m milestone payment from Bristol Myers Squibb for IND acceptance in protein degradation partnership, advancing drug candidate towards Phase 1 clinical trial Evotec Milestone Payment Bristol Myers Squibb Protein Degradation IND Acceptance
BRIEF published on 11/05/2025 at 07:35, 1 year ago Evotec SE annonce des résultats solides pour les 9 premiers mois de l'année 2025, avec une orientation stratégique. Evotec SE Croissance Des Produits Biologiques Alliances Stratégiques Résultats 9M 2025 Transaction Sandoz
BRIEF published on 11/05/2025 at 07:35, 1 year ago Evotec SE Reports Resilient 9M 2025 Results with Strategic Focus Strategic Alliances Evotec SE Biologics Growth 9M 2025 Results Sandoz Transaction
PRESS RELEASE published on 11/05/2025 at 07:30, 1 year ago Evotec SE reports 9M 2025 results: Continued strong execution on strategic priorities Evotec SE reports 9M 2025 results with €535.1m group revenues, strong scientific advancements, landmark industry transaction, and confirmed 2025 guidance and 2028 outlook Strategic Priorities Evotec SE 9M Results 2028 Outlook Landmark Industry Transaction
BRIEF published on 11/04/2025 at 22:10, 1 year ago Evotec Signs Milestone Agreement with Sandoz, Eyes Substantial Revenue Pharmaceutical Industry Biosimilars Evotec Manufacturing Technology Sandoz
BRIEF published on 11/04/2025 at 22:10, 1 year ago Evotec signe un accord historique avec Sandoz et vise des revenus substantiels. Evotec Biosimilaires Industrie Pharmaceutique Technologie De Fabrication Sandoz
PRESS RELEASE published on 11/04/2025 at 22:05, 1 year ago In a landmark industry transaction, Evotec signs agreement with Sandoz, resulting in payments potentially over US$ 650 m plus royalties Evotec SE signs landmark agreement with Sandoz, leading to over US$650m in payments plus royalties. Deal includes acquisition of manufacturing site and technology license fees Evotec SE Payments Biosimilars Agreement Sandoz
BRIEF published on 10/29/2025 at 09:50, 1 year ago Evotec SE to Release Q3 2025 Financial Results on November 5th Financial Results Conference Call Life Sciences Evotec SE 2025 Performance
BRIEF published on 10/29/2025 at 09:50, 1 year ago Evotec SE publiera ses résultats financiers du troisième trimestre 2025 le 5 novembre. Résultats Financiers Evotec SE Conférence Téléphonique Sciences De La Vie Performances 2025
PRESS RELEASE published on 10/29/2025 at 09:45, 1 year ago Evotec SE to announce results for the first nine months 2025 on 05 November 2025 Evotec SE to announce results for the first nine months 2025 on 05 November 2025. The Company will hold a conference call in English to discuss the interim statement Conference Call Financial Report Evotec SE Results Interim Statement
Published on 11/18/2026 at 00:35, 3 hours 43 minutes ago Route1 Appoints Tom Park to Board of Directors and Announces Board Changes
Published on 11/17/2026 at 23:40, 4 hours 38 minutes ago AI/ML Innovations Inc. Closes First Tranche of Private Placement
Published on 11/17/2026 at 23:00, 5 hours 18 minutes ago Alset AI Ventures Inc. Announces Extension of Annual General Meeting Deadline
Published on 11/17/2026 at 21:30, 6 hours 48 minutes ago Fairplay Ventures INC. Announces Filing of Filing Statement in Connection With Qualifying Transaction
Published on 11/17/2026 at 15:00, 13 hours 18 minutes ago Secure Blockchain's Agentic Solutions Signs Engineering Company, Expanding Enterprise AI Into Heavy Industry
Published on 11/18/2026 at 03:15, 1 hour 2 minutes ago China’s Recombinant Collagen Technology Wins the INPD Innovative Manufacturing Process Award
Published on 11/18/2026 at 03:15, 1 hour 2 minutes ago La technologie chinoise du collagène recombinant remporte le prix INPD du procédé de fabrication innovant
Published on 11/18/2026 at 01:55, 2 hours 22 minutes ago WIRobotics and Ottobock Join Forces to Expand Access to Wearable Robots Across North America
Published on 11/18/2026 at 01:40, 2 hours 37 minutes ago AMPERA and Berto Announce Proposed Business Combination to Accelerate Advanced Energy Technology Development and Commercialization
Published on 11/18/2026 at 00:59, 3 hours 18 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 11/17/2026 at 18:00, 10 hours 18 minutes ago 20261117 - Accor - Accor to increase its stake in Ennismore
Published on 11/17/2026 at 18:00, 10 hours 18 minutes ago Accor - Accor se renforce au capital de Ennismore
Published on 11/17/2026 at 17:45, 10 hours 33 minutes ago EURAZEO COMPLETES THE SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT ALONGSIDE PARTNERS GROUP
Published on 11/17/2026 at 17:45, 10 hours 33 minutes ago EURAZEO FINALISE LA CESSION DE SA PARTICIPATION DANS AROMA-ZONE ET SON REINVESTISSEMENT AUX COTES DE PARTNERS GROUP
Published on 11/17/2026 at 07:40, 20 hours 37 minutes ago SUEZ INTERNATIONAL SAS COMPLETES THE SALE OF C.10.65 MILLION SHARES OF ACEA S.P.A.